The Efficacy of CILostazol ON Ischemic Complications After DES Implantation

NCT00776828 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

960

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: cilostazol

Sponsor

Seoul National University Hospital